Dynamics of the tumor immune microenvironment during ne-oadjuvant chemotherapy of high-grade serous ovarian cancer
Authors/Creators
- 1. Department of Obstetrics and Gynecology, Institute of Women's Medical Life Science, Yonsei Universi-ty College of Medicine, Seoul, Republic of Korea
Description
Supplementary Figure S1: quanTIseq analysis of immune cell fraction
(a) Correlation between immune cell fraction and maker expression
(b) Comparison of immune cell fraction between pre- and post-NAC tumor samples
Supplementary Figure S2: Forest plot showing the association between immune cell fractions, plati-num sensitivity, and progression-free survival rate at 12 months
Supplementary Figure S3: Gene set enrichment analysis of differentially expressed genes in pre- and post-NAC samples.
Supplemental Table S1. Gene content in the TruSight Tumor 170 panel